Health Products Act 2007 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment No. 2) Regulations 2023 |
|
Citation and commencement |
1. These Regulations are the Health Products (Cell, Tissue and Gene Therapy Products) (Amendment No. 2) Regulations 2023 and come into operation on 18 December 2023. |
Amendment of regulation 2 |
2. In the Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (G.N. No. S 104/2021) (called in these Regulations the principal Regulations), in regulation 2(1) —
|
Amendment of regulation 9 |
3. In the principal Regulations, in regulation 9(a) —
|
Amendment of regulation 12 |
4. In the principal Regulations, in regulation 12 —
|
Amendment of regulation 15 |
5. In the principal Regulations, in regulation 15(1) —
|
Amendment of regulation 16 |
6. In the principal Regulations, in regulation 16(1), delete “(eb),”. |
Amendment of regulation 18 |
7. In the principal Regulations, in regulation 18 —
|
Amendment of regulation 21 |
8. In the principal Regulations, in regulation 21, delete paragraph (b). |
Amendment of regulation 26 |
9. In the principal Regulations, in regulation 26(1)(b)(i), delete “nursing home or” wherever it appears. |
Amendment of regulation 33 |
10. In the principal Regulations, in regulation 33(1)(b), delete “, (eb)”. |
Amendment of regulation 34 |
11. In the principal Regulations, in regulation 34 —
|
Amendment of regulation 40 |
12. In the principal Regulations, in regulation 40(a)(iii) —
|
Amendment of regulation 53 |
13. In the principal Regulations, in regulation 53(1)(b), replace “an active substance or” with “a”. |
Amendment of regulation 54 |
14. In the principal Regulations, in regulation 54(1)(b), replace “an active substance or” with “a”. |
Chairperson, Health Sciences Authority, Singapore. |
[78:44/1; 401:04/01-000; AG/LEGIS/SL/122D/2020/13 Vol. 1] |
(To be presented to Parliament under section 72(5) of the Health Products Act 2007). |